Skip to content
10-Q

Quarterly Report

Eucrates Biomedical Acquisition Corp.

0001410578-22-003416

← back to feed
Filed
Nov 14, 2022 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Nov 14, 2022 4.21M sh
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$239.11K
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$345.05K
Cash And Equivalents Q3 2022 · Sep 30, 2022 $60.04K
Cash And Equivalents Q3 2022 · Dec 31, 2021 $49.16K
Cash And Equivalents Q3 2022 · Sep 30, 2021 $206.22K
Cash And Equivalents Q3 2022 · Dec 31, 2020 $551.26K
Stockholders Equity Q3 2022 · Sep 30, 2022 −$3.73M
Stockholders Equity Q3 2022 · Jun 30, 2022 −$3.79M
Stockholders Equity Q3 2022 · Mar 31, 2022 −$4.16M
Stockholders Equity Q3 2022 · Dec 31, 2021 −$5.49M
Stockholders Equity Q3 2022 · Sep 30, 2021 −$5.74M
Stockholders Equity Q3 2022 · Jun 30, 2021 −$6.69M
Stockholders Equity Q3 2022 · Mar 31, 2021 −$7.32M
Stockholders Equity Q3 2022 · Dec 31, 2020 −$9.31M
Current Liabilities Q3 2022 · Sep 30, 2022 $119.81K
Current Liabilities Q3 2022 · Dec 31, 2021 $38.46K
Total Liabilities Q3 2022 · Sep 30, 2022 $3.93M
Total Liabilities Q3 2022 · Dec 31, 2021 $5.8M
Current Assets Q3 2022 · Sep 30, 2022 $97.25K
Current Assets Q3 2022 · Dec 31, 2021 $264.16K
Total Assets Q3 2022 · Sep 30, 2022 $105.52M
Total Assets Q3 2022 · Dec 31, 2021 $105.11M
Net Income Q3 2022 · Sep 30, 2022 $521.34K
Net Income Q3 2022 · Sep 30, 2022 $2.28M
Net Income Q3 2022 · Jun 30, 2022 $431.66K
Net Income Q3 2022 · Mar 31, 2022 $1.32M
Net Income Q3 2022 · Sep 30, 2021 $950.22K
Net Income Q3 2022 · Sep 30, 2021 $3.57M
Net Income Q3 2022 · Jun 30, 2021 $630.59K
Net Income Q3 2022 · Mar 31, 2021 $1.99M
Operating Income Q3 2022 · Sep 30, 2022 −$166.87K
Operating Income Q3 2022 · Sep 30, 2022 −$435.39K
Operating Income Q3 2022 · Sep 30, 2021 −$259.86K
Operating Income Q3 2022 · Sep 30, 2021 −$509.63K